Works matching IS 2160763X AND DT 2022 AND VI 11 AND IP 11


Results: 13
    1

    Issue Information.

    Published in:
    Clinical Pharmacology in Drug Development, 2022, v. 11, n. 11, p. 1241, doi. 10.1002/cpdd.833
    Publication type:
    Article
    2
    3
    4
    5

    Bioequivalence and Relative Bioavailability Studies to Assess a New Acalabrutinib Formulation That Enables Coadministration With Proton‐Pump Inhibitors.

    Published in:
    Clinical Pharmacology in Drug Development, 2022, v. 11, n. 11, p. 1294, doi. 10.1002/cpdd.1153
    By:
    • Sharma, Shringi;
    • Pepin, Xavier;
    • Burri, Harini;
    • Zheng, Lianqing;
    • Kuptsova‐Clarkson, Nataliya;
    • de Jong, Anouk;
    • Yu, Ting;
    • MacArthur, Holly L.;
    • Majewski, Michal;
    • Byrd, John C.;
    • Furman, Richard R.;
    • Ware, Joseph A.;
    • Mann, James;
    • Ramies, David;
    • Munugalavadla, Veerendra;
    • Sheridan, Louise;
    • Tomkinson, Helen
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13

    Pharmacokinetic Characteristics, Safety, and Tolerability of Telitacicept, an Injectable Recombinant Human B‐Lymphocyte Stimulating Factor Receptor‐Antibody Fusion Protein, in Healthy Chinese Subjects.

    Published in:
    Clinical Pharmacology in Drug Development, 2022, v. 11, n. 11, p. 1273, doi. 10.1002/cpdd.1136
    By:
    • Xie, Jing;
    • Fan, Xiaoyun;
    • Su, Yue;
    • Zhou, Huan;
    • Cao, Shugang;
    • Zhu, Xingyu;
    • Zhu, Minhui;
    • He, Cuixia;
    • Wang, Ying;
    • Fan, Ling;
    • Ge, Qin;
    • Zhu, Juan;
    • Liu, Bingyan;
    • Chen, Xiao;
    • Xie, Yunqiu;
    • Ma, Ling;
    • Liu, Yuanyuan;
    • Chen, Juan;
    • Wang, Huaxue;
    • Li, Zhijun
    Publication type:
    Article